» Articles » PMID: 27169894

3D Printing of Tissue Engineered Constructs for In Vitro Modeling of Disease Progression and Drug Screening

Overview
Journal Ann Biomed Eng
Date 2016 May 13
PMID 27169894
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

2D cell culture and preclinical animal models have traditionally been implemented for investigating the underlying cellular mechanisms of human disease progression. However, the increasing significance of 3D vs. 2D cell culture has initiated a new era in cell culture research in which 3D in vitro models are emerging as a bridge between traditional 2D cell culture and in vivo animal models. Additive manufacturing (AM, also known as 3D printing), defined as the layer-by-layer fabrication of parts directed by digital information from a 3D computer-aided design file, offers the advantages of simultaneous rapid prototyping and biofunctionalization as well as the precise placement of cells and extracellular matrix with high resolution. In this review, we highlight recent advances in 3D printing of tissue engineered constructs that recapitulate the physical and cellular properties of the tissue microenvironment for investigating mechanisms of disease progression and for screening drugs.

Citing Articles

3D Bioprinting in Cancer Modeling and Biomedicine: From Print Categories to Biological Applications.

Yang J, Wang L, Wu R, He Y, Zhao Y, Wang W ACS Omega. 2024; 9(44):44076-44100.

PMID: 39524656 PMC: 11541486. DOI: 10.1021/acsomega.4c06051.


Three-Dimensional Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research.

Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran D, Isidoro C Int J Biol Sci. 2024; 20(13):5293-5311.

PMID: 39430243 PMC: 11488579. DOI: 10.7150/ijbs.96469.


Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach.

Saberian E, Jenca A, Petrasova A, Zare-Zardini H, Ebrahimifar M Pharmaceutics. 2024; 16(6).

PMID: 38931923 PMC: 11207321. DOI: 10.3390/pharmaceutics16060802.


A Comprehensive Mechanical Characterization of Subject-Specific 3D Printed Scaffolds Mimicking Trabecular Bone Architecture Biomechanics.

Rojas-Rojas L, Tozzi G, Guillen-Giron T Life (Basel). 2023; 13(11).

PMID: 38004281 PMC: 10672154. DOI: 10.3390/life13112141.


Engineering Heterogeneous Tumor Models for Biomedical Applications.

Wu Z, Huang D, Wang J, Zhao Y, Sun W, Shen X Adv Sci (Weinh). 2023; 11(1):e2304160.

PMID: 37946674 PMC: 10767453. DOI: 10.1002/advs.202304160.


References
1.
Zhang D, Pekkanen-Mattila M, Shahsavani M, Falk A, Teixeira A, Herland A . A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials. 2013; 35(5):1420-8. DOI: 10.1016/j.biomaterials.2013.11.028. View

2.
Chang R, Nam J, Sun W . Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng Part C Methods. 2008; 14(2):157-66. DOI: 10.1089/ten.tec.2007.0392. View

3.
Murphy S, Atala A . 3D bioprinting of tissues and organs. Nat Biotechnol. 2014; 32(8):773-85. DOI: 10.1038/nbt.2958. View

4.
Hutmacher D . Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000; 21(24):2529-43. DOI: 10.1016/s0142-9612(00)00121-6. View

5.
Groll J, Boland T, Blunk T, Burdick J, Cho D, Dalton P . Biofabrication: reappraising the definition of an evolving field. Biofabrication. 2016; 8(1):013001. DOI: 10.1088/1758-5090/8/1/013001. View